Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  PI3K/mTOR/ALK-1/DNA-PK inhibitor P7170
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 90
Trial IDs: P7170/70/11, NCI-2013-00315, NCT01762410
Start Over